Proteomics firm Antigen Discovery said this week that it has received two Small Business Innovation Research awards totaling roughly $3.1 million for work on protein biomarkers for malaria and an integrated microfluidic point-of-care diagnostic device.

The malaria biomarker award is a three-year, Phase II SBIR grant from the National Institute of Allergy and Infectious Disease totaling $2.5 million. The microfluidic device award is a Phase I SBIR grant, also from the NIAID, totaling $600,000.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.